These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22679362)

  • 1. Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide.
    Youshia J; Kamel AO; El Shamy A; Mansour S
    Int J Nanomedicine; 2012; 7():2483-96. PubMed ID: 22679362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of methazolamide-loaded solid lipid nanoparticles for ophthalmic delivery using Box-Behnken design.
    Wang F; Chen L; Jiang S; He J; Zhang X; Peng J; Xu Q; Li R
    J Liposome Res; 2014 Sep; 24(3):171-81. PubMed ID: 24611687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugs.
    Youshia J; Kamel AO; El Shamy A; Mansour S
    Eur J Pharm Sci; 2021 Aug; 163():105887. PubMed ID: 34022410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructured lipid carriers for intraocular brimonidine localisation: development, in-vitro and in-vivo evaluation.
    El-Salamouni NS; Farid RM; El-Kamel AH; El-Gamal SS
    J Microencapsul; 2018 Jan; 35(1):102-113. PubMed ID: 29310481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
    Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O
    Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles - Formulation and Pharmacodynamic Assessment.
    Awadeen RH; Boughdady MF; Meshali MM
    Int J Nanomedicine; 2020; 15():8553-8568. PubMed ID: 33173292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
    Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study.
    Wang F; Chen L; Zhang D; Jiang S; Shi K; Huang Y; Li R; Xu Q
    J Drug Target; 2014 Nov; 22(9):849-58. PubMed ID: 25045926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
    Rathod VR; Shah DA; Dave RH
    Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coated Lipidic Nanoparticles as a New Strategy for Enhancing Nose-to-Brain Delivery of a Hydrophilic Drug Molecule.
    Salem LH; El-Feky GS; Fahmy RH; El Gazayerly ON; Abdelbary A
    J Pharm Sci; 2020 Jul; 109(7):2237-2251. PubMed ID: 32320670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of acyclovir-loaded solid lipid nanoparticles: design, optimization, and
    El-Gizawy SA; El-Maghraby GM; Hedaya AA
    Pharm Dev Technol; 2019 Dec; 24(10):1287-1298. PubMed ID: 31507232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insight for Enhanced Topical Targeting of Caffeine for Effective Cellulite Treatment: In Vitro Characterization, Permeation Studies, and Histological Evaluation in Rats.
    Fouad SA; Badr TA; Abdelbary A; Fadel M; Abdelmonem R; Jasti BR; El-Nabarawi M
    AAPS PharmSciTech; 2024 Oct; 25(7):237. PubMed ID: 39384727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
    Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
    Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
    Thirupathi G; Swetha E; Narendar D
    Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
    Attama AA; Müller-Goymann CC
    Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization,
    Abdelmonem R; Al-Samadi IEI; El Nashar RM; Jasti BR; El-Nabarawi MA
    Drug Deliv; 2022 Dec; 29(1):2868-2882. PubMed ID: 36065090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.